首页 > 最新文献

Seminars in Integrative Medicine最新文献

英文 中文
Vanilla as a Medicinal Plant 香草作为药用植物
Pub Date : 2005-12-01 DOI: 10.1016/j.sigm.2006.03.001
Jenna Deanne Bythrow MS, BS, BA

Vanilla has been coveted over the ages for culinary and medicinal reasons alike. Vanilla’s high status in the culinary world comes from a long history of flavoring sweet, sensual desserts such as ice cream, sugar cookies, puff pastries, and butter creams. While vanilla’s history is steeped in culinary traditions, its lesser know uses as an aphrodisiac and a medical botanical stretch back to its discovery in Mesoamerica by ancient cultures who cultivated and honored the sweet orchid. European nations also historically valued vanilla for its flavor, its lore as a love potion, and its medicinal uses. While traditional medical uses of vanilla have faded away, its culinary traditions have changed little. Present day advances in basic science research have shed light on the medical benefits of vanillin, vanilla’s active constituent.

多年来,香草一直因烹饪和药用原因而令人垂涎。香草在烹饪界的崇高地位源于其在冰淇淋、糖饼干、泡芙糕点和黄油奶油等甜而感性的甜点中的悠久历史。虽然香草的历史沉浸在烹饪传统中,但它作为催情药和药用植物的鲜为人知的用途可以追溯到中美洲的古代文化,他们种植并尊重甜兰花。欧洲国家在历史上也重视香草,因为它的味道,它作为爱情药水的传说,以及它的药用价值。虽然香草的传统医学用途已经消失,但它的烹饪传统却几乎没有改变。目前,基础科学研究的进展已经阐明了香草素的医疗效益,香草的有效成分。
{"title":"Vanilla as a Medicinal Plant","authors":"Jenna Deanne Bythrow MS, BS, BA","doi":"10.1016/j.sigm.2006.03.001","DOIUrl":"10.1016/j.sigm.2006.03.001","url":null,"abstract":"<div><p>Vanilla has been coveted over the ages for culinary and medicinal reasons alike. Vanilla’s high status in the culinary world comes from a long history of flavoring sweet, sensual desserts such as ice cream, sugar cookies, puff pastries, and butter creams. While vanilla’s history is steeped in culinary traditions, its lesser know uses as an aphrodisiac and a medical botanical stretch back to its discovery in Mesoamerica by ancient cultures who cultivated and honored the sweet orchid. European nations also historically valued vanilla for its flavor, its lore as a love potion, and its medicinal uses. While traditional medical uses of vanilla have faded away, its culinary traditions have changed little. Present day advances in basic science research have shed light on the medical benefits of vanillin, vanilla’s active constituent.</p></div>","PeriodicalId":101156,"journal":{"name":"Seminars in Integrative Medicine","volume":"3 4","pages":"Pages 129-131"},"PeriodicalIF":0.0,"publicationDate":"2005-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.sigm.2006.03.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87515270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 63
New Orleans Pharmacy Museum 新奥尔良药房博物馆
Pub Date : 2005-12-01 DOI: 10.1016/j.sigm.2006.03.003
Jennifer Lushear Gick
{"title":"New Orleans Pharmacy Museum","authors":"Jennifer Lushear Gick","doi":"10.1016/j.sigm.2006.03.003","DOIUrl":"10.1016/j.sigm.2006.03.003","url":null,"abstract":"","PeriodicalId":101156,"journal":{"name":"Seminars in Integrative Medicine","volume":"3 4","pages":"Pages 111-112"},"PeriodicalIF":0.0,"publicationDate":"2005-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.sigm.2006.03.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80178993","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Time-Varying, Biaxial Magnetic Stimulation in Refractory Carpal Tunnel Syndrome: A Novel Approach. A Pilot Study 时变双轴磁刺激治疗难治性腕管综合征:一种新方法。一项初步研究
Pub Date : 2005-12-01 DOI: 10.1016/j.sigm.2006.03.002
Michael I. Weintraub MD, FACP, FAAN , Steven P. Cole PhD

A pilot study was conducted to determine whether a cumulative 1-h daily exposure to a portable biaxial pulsed magnetic field stimulator over the carpal tunnel region for a 2-week period could reduce neuropathic pain scores and influence sleep interruption and possibly be an alternative conservative therapy option. Patients with advanced carpal tunnel syndrome (CTS) have often failed conservative therapy and are left with refractory numbness, tingling, and burning pain with disability. Previously, we demonstrated that constant application of static permanent magnets to the wrists for a 1-month period reduced neuropathic pain (NP) and improved motor distal latency of the median nerve compared with placebo. Since pulsed time-varying magnetic fields are capable of inducing changes within biological tissues and influencing signal transduction and reducing musculoskeletal pain, we postulated that nociceptive sensory fibers within the carpal tunnel could be influenced at a neuronal level. Thirty-five symptomatic hands (23 subjects) with medical and/or surgically refractory symptoms were enrolled in this nonplacebo trial. Baseline daily NP and sleep interruption scores (VAS 0-10) were tabulated. A distal median nerve latency was performed at baseline and at end of trial. A portable device (Palm Mag) was given to each patient to take home and apply daily for 1 h. This device generates a minimum to maximum sweep of 8-23 Hz at the target area. There is a maximum sweep of 1400 rotations/s. Daily VAS scores were maintained and statistical analyses (two-tailed t-test) were performed. Twenty-nine hands (19 subjects) completed this 2-week study with 6 dropouts (4 subjects). There was a significant reduction in NP scores, especially in the moderate–severe cohort, VAS 5.0-10, (P < 0.05). Sleep interruption scores were also reduced (P < 0.01). There were no changes in neurological examination or electrophysiological testing serially. There were no safety issues. Despite absence of placebo controls, these novel preliminary pilot data demonstrating short-term antinociceptive benefit suggest the feasibility of future trials using randomized, placebo-controlled design. If biologically positive, it would suggest that time-varying magnetic fields targeting the carpal tunnel region will be a future conservative therapeutic option.

进行了一项初步研究,以确定在腕管区域每天累计暴露1小时的便携式双轴脉冲磁场刺激器2周是否可以减少神经性疼痛评分和影响睡眠中断,并可能作为一种替代保守治疗选择。晚期腕管综合征(CTS)患者通常保守治疗失败,留下难治性麻木、刺痛和灼痛伴残疾。先前,我们证明了与安慰剂相比,在手腕上持续应用静态永磁体1个月可以减少神经性疼痛(NP),改善正中神经的运动远端潜伏期。由于脉冲时变磁场能够诱导生物组织内的变化,影响信号转导并减少肌肉骨骼疼痛,我们假设腕管内的伤害感觉纤维可能在神经元水平上受到影响。35只有内科和/或手术难治性症状的手(23名受试者)被纳入这项非安慰剂试验。将基线每日NP和睡眠中断评分(VAS 0-10)制成表格。在基线和试验结束时进行远端正中神经潜伏期。给每位患者一个便携式设备(Palm Mag)带回家,每天使用1小时。该设备在目标区域产生最小到最大8-23 Hz的扫描。最大扫描速度为1400转/秒。维持每日VAS评分并进行统计学分析(双尾t检验)。29只手(19名受试者)完成了为期2周的研究,6名受试者(4名受试者)退出。NP评分显著降低,特别是在中重度队列,VAS 5.0-10, (P <0.05)。睡眠中断评分也有所降低(P <0.01)。神经学检查和电生理检查均无明显变化。没有安全问题。尽管缺乏安慰剂对照,这些新颖的初步试验数据显示短期抗痛觉获益,表明未来试验采用随机、安慰剂对照设计的可行性。如果生物学阳性,则表明针对腕管区域的时变磁场将是未来的保守治疗选择。
{"title":"Time-Varying, Biaxial Magnetic Stimulation in Refractory Carpal Tunnel Syndrome: A Novel Approach. A Pilot Study","authors":"Michael I. Weintraub MD, FACP, FAAN ,&nbsp;Steven P. Cole PhD","doi":"10.1016/j.sigm.2006.03.002","DOIUrl":"10.1016/j.sigm.2006.03.002","url":null,"abstract":"<div><p><span><span><span>A pilot study was conducted to determine whether a cumulative 1-h daily exposure to a portable biaxial pulsed magnetic field stimulator over the carpal tunnel region for a 2-week period could reduce neuropathic pain scores and influence sleep interruption and possibly be an alternative conservative therapy option. Patients with advanced carpal tunnel syndrome (CTS) have often failed conservative therapy and are left with refractory numbness, tingling, and burning pain with disability. Previously, we demonstrated that constant application of static permanent magnets to the wrists for a 1-month period reduced neuropathic pain (NP) and improved motor distal latency of the </span>median nerve<span> compared with placebo. Since pulsed time-varying magnetic fields are capable of inducing changes within biological tissues and influencing signal transduction and reducing </span></span>musculoskeletal pain<span>, we postulated that nociceptive sensory fibers within the carpal tunnel could be influenced at a neuronal level. Thirty-five symptomatic hands (23 subjects) with medical and/or surgically refractory symptoms were enrolled in this nonplacebo trial. Baseline daily NP and sleep interruption scores (VAS 0-10) were tabulated. A distal median nerve latency was performed at baseline and at end of trial. A portable device (Palm Mag) was given to each patient to take home and apply daily for 1 h. This device generates a minimum to maximum sweep of 8-23 Hz at the target area. There is a maximum sweep of 1400 rotations/s. Daily VAS scores were maintained and statistical analyses (two-tailed </span></span><em>t</em>-test) were performed. Twenty-nine hands (19 subjects) completed this 2-week study with 6 dropouts (4 subjects). There was a significant reduction in NP scores, especially in the moderate–severe cohort, VAS 5.0-10, (<em>P</em> &lt; 0.05). Sleep interruption scores were also reduced (<em>P</em><span> &lt; 0.01). There were no changes in neurological examination or electrophysiological testing serially. There were no safety issues. Despite absence of placebo controls, these novel preliminary pilot data demonstrating short-term antinociceptive benefit suggest the feasibility of future trials using randomized, placebo-controlled design. If biologically positive, it would suggest that time-varying magnetic fields targeting the carpal tunnel region will be a future conservative therapeutic option.</span></p></div>","PeriodicalId":101156,"journal":{"name":"Seminars in Integrative Medicine","volume":"3 4","pages":"Pages 123-128"},"PeriodicalIF":0.0,"publicationDate":"2005-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.sigm.2006.03.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78182453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Tobacco from Medicinal Use to Substance Abuse 烟草从药用到药物滥用
Pub Date : 2005-12-01 DOI: 10.1016/j.sigm.2006.04.002
Serggio C. Lanata MS
{"title":"Tobacco from Medicinal Use to Substance Abuse","authors":"Serggio C. Lanata MS","doi":"10.1016/j.sigm.2006.04.002","DOIUrl":"10.1016/j.sigm.2006.04.002","url":null,"abstract":"","PeriodicalId":101156,"journal":{"name":"Seminars in Integrative Medicine","volume":"3 4","pages":"Pages 132-138"},"PeriodicalIF":0.0,"publicationDate":"2005-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.sigm.2006.04.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80989150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Forthcoming issue/Masthead 即将出版/报头
Pub Date : 2005-12-01 DOI: 10.1016/S1543-1150(06)00008-1
{"title":"Forthcoming issue/Masthead","authors":"","doi":"10.1016/S1543-1150(06)00008-1","DOIUrl":"https://doi.org/10.1016/S1543-1150(06)00008-1","url":null,"abstract":"","PeriodicalId":101156,"journal":{"name":"Seminars in Integrative Medicine","volume":"3 4","pages":"Page CO2"},"PeriodicalIF":0.0,"publicationDate":"2005-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1543-1150(06)00008-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136903246","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Homeopathic Drug Standardization 顺势疗法药物标准化
Pub Date : 2005-12-01 DOI: 10.1016/j.sigm.2006.04.001
Jahangir Satti PhD

Advancements in scientific techniques have enabled researchers to critically examine and scrutinize nonconventional therapies to either validate or reject them for routine clinical practice. The substantiation of the homeopathic system has been controversial since there is no standard drug dilution strength that can be subjected to clinical tests. Homeopaths usually claim to achieve curative effects by using homeopathic substances ranging in concentration from mother tinctures in crude forms to infinitesimal dilutions with a probability of almost zero active ingredients in them. The issue becomes further confused when different criteria are applied to drug dilution preparations that are inconsistent with any established scientific metric such as Avogadro’s number. This fact was well known to its founder, Dr. Hahnemann, who tried to establish drug standardization around the 30th dilution during his last years of life. He even developed a semi-nonlinear method, known as LM potencies, which was revealed in his postmortem publication of Organon of Medicine, 6th edition, in 1921. Dr. Hering, founder of American Homeopathy, devised the decimal dilution method, which, like the earlier dilution methods, lacked any fundamental metric such as Avogadro’s number. A literature search revealed that the drug dilution and standardization issues were never settled in homeopathy. The issues of miracle cures with different dilutions become questionable when such claims are examined in the absence of any placebo or control studies. In short, homeopathy has failed to establish validity of its dilutions’ effects in general research settings. The common denominator to all such failures can be attributed to the absence of standardization of drug dilutions based on scientific metrics. Different drugs are composed of different numbers of atoms/molecules to start with. A single linear no-threshold method cannot standardize the heterogeneous drugs to a desired unique scale. A nonlinear method is needed to standardize homeopathic drugs to a single scale such as the 30th to either validate or reject them on scientific grounds. This issue becomes more important in the light of new emerging nanotechnology. Homeopathic drug standardization based on scientific metrics is needed for research and reproducibility for routine clinical practice.

科学技术的进步使研究人员能够严格检查和审查非常规疗法,以验证或拒绝常规临床实践。顺势疗法系统的证实一直存在争议,因为没有标准的药物稀释强度可以进行临床试验。顺势疗法医生通常声称通过使用顺势疗法物质来达到疗效,其浓度从原始形式的母体酊剂到极少量的稀释剂,其中几乎没有活性成分的可能性。当不同的标准应用于与任何既定科学度量(如阿伏伽德罗数)不一致的药物稀释制剂时,问题变得更加混乱。它的创始人哈内曼博士很清楚这一点,他在生命的最后几年里试图在30倍稀释度左右建立药物标准化。他甚至发明了一种半非线性的方法,被称为LM效力,并在1921年出版的《医学原理》第六版中发表。赫林博士是美国顺势疗法的创始人,他发明了十进制稀释法,和早期的稀释法一样,这种方法没有任何基本的度量,比如阿伏伽德罗数。文献检索显示,顺势疗法的药物稀释和标准化问题从未得到解决。在没有任何安慰剂或对照研究的情况下,对不同稀释度的奇迹般的治疗方法进行检验时,问题就变得值得怀疑了。简而言之,顺势疗法未能在一般研究环境中建立其稀释效果的有效性。所有这些失败的共同点可归因于缺乏基于科学指标的药物稀释度标准化。不同的药物是由不同数量的原子/分子组成的。单一的线性无阈值方法无法将异质性药物标准化到所需的唯一标度。需要一种非线性的方法来将顺势疗法药物标准化到单一的尺度,比如第30个尺度,从而在科学的基础上验证或拒绝它们。鉴于新兴的纳米技术,这个问题变得更加重要。顺势疗法药物标准化需要建立在科学指标的基础上,以促进常规临床实践的研究和可重复性。
{"title":"Homeopathic Drug Standardization","authors":"Jahangir Satti PhD","doi":"10.1016/j.sigm.2006.04.001","DOIUrl":"10.1016/j.sigm.2006.04.001","url":null,"abstract":"<div><p>Advancements in scientific techniques have enabled researchers to critically examine and scrutinize nonconventional therapies to either validate or reject them for routine clinical practice. The substantiation of the homeopathic system has been controversial since there is no standard drug dilution strength that can be subjected to clinical tests. Homeopaths usually claim to achieve curative effects by using homeopathic substances ranging in concentration from mother tinctures in crude forms to infinitesimal dilutions with a probability of almost zero active ingredients in them. The issue becomes further confused when different criteria are applied to drug dilution preparations that are inconsistent with any established scientific metric such as Avogadro’s number. This fact was well known to its founder, Dr. Hahnemann, who tried to establish drug standardization around the 30th dilution during his last years of life. He even developed a semi-nonlinear method, known as LM potencies, which was revealed in his postmortem publication of <em>Organon of Medicine</em>, 6th edition, in 1921. Dr. Hering, founder of American Homeopathy, devised the decimal dilution method, which, like the earlier dilution methods, lacked any fundamental metric such as Avogadro’s number. A literature search revealed that the drug dilution and standardization issues were never settled in homeopathy. The issues of miracle cures with different dilutions become questionable when such claims are examined in the absence of any placebo or control studies. In short, homeopathy has failed to establish validity of its dilutions’ effects in general research settings. The common denominator to all such failures can be attributed to the absence of standardization of drug dilutions based on scientific metrics. Different drugs are composed of different numbers of atoms/molecules to start with. A single linear no-threshold method cannot standardize the heterogeneous drugs to a desired unique scale. A nonlinear method is needed to standardize homeopathic drugs to a single scale such as the 30th to either validate or reject them on scientific grounds. This issue becomes more important in the light of new emerging nanotechnology. Homeopathic drug standardization based on scientific metrics is needed for research and reproducibility for routine clinical practice.</p></div>","PeriodicalId":101156,"journal":{"name":"Seminars in Integrative Medicine","volume":"3 4","pages":"Pages 113-122"},"PeriodicalIF":0.0,"publicationDate":"2005-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.sigm.2006.04.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75906984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
The Institute of Medicine’s Report on Complementary and Alternative Medicine in the United States: A Reflection 美国医学研究所关于补充和替代医学的报告:反思
Pub Date : 2005-09-01 DOI: 10.1016/j.sigm.2005.08.002
Michael H. Cohen JD, MBA
{"title":"The Institute of Medicine’s Report on Complementary and Alternative Medicine in the United States: A Reflection","authors":"Michael H. Cohen JD, MBA","doi":"10.1016/j.sigm.2005.08.002","DOIUrl":"10.1016/j.sigm.2005.08.002","url":null,"abstract":"","PeriodicalId":101156,"journal":{"name":"Seminars in Integrative Medicine","volume":"3 3","pages":"Pages 75-76"},"PeriodicalIF":0.0,"publicationDate":"2005-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.sigm.2005.08.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77664633","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Innovative Approach to Migraine Headache and Other Neurologic Conditions 偏头痛和其他神经系统疾病的创新方法
Pub Date : 2005-09-01 DOI: 10.1016/j.sigm.2005.10.002
Thomas J. Sabuda DDS
{"title":"Innovative Approach to Migraine Headache and Other Neurologic Conditions","authors":"Thomas J. Sabuda DDS","doi":"10.1016/j.sigm.2005.10.002","DOIUrl":"10.1016/j.sigm.2005.10.002","url":null,"abstract":"","PeriodicalId":101156,"journal":{"name":"Seminars in Integrative Medicine","volume":"3 3","pages":"Pages 93-100"},"PeriodicalIF":0.0,"publicationDate":"2005-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.sigm.2005.10.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77644900","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
First Line Comprehensive Care. Part II: Anthropogenic Xenobiotics in Functional Medicine. Managing Persisting Bioaccumulating Pollutants: Toxic Minerals, Biocides, Hormone Mimics, Solvents, and Chemical Disruptors 一线综合护理。第二部分:功能医学中的人为外源药物。管理持续的生物积累污染物:有毒矿物质,杀菌剂,激素模拟物,溶剂和化学干扰物
Pub Date : 2005-09-01 DOI: 10.1016/j.sigm.2005.11.001
Russell Jaffe MD, PhD, CCN, NACB

First line comprehensive care is fundamental to integrative medicine, an emerging specialty within American healthcare. Primary focus is on functional and predictive tests to identify remediable causes of suffering and ill health. Integrative health professionals are learning a more functional language—it is both a language of causes and of deeper insights into more fundamental molecular and submolecular mechanisms of both our good health and our ill health. Anthropogenic xenobiotics, especially the bioaccumulating and bioconcentrating toxic minerals (TMs) and persistent organic pollutants (POPs) are the focus of this article as they are, in their more toxic forms, largely anthropogenic, human-sourced intoxicants. Bioconcentration operates in the following way: Ocean krill and algae convert less toxic, inorganic mercury to biotoxic organic mercury. Alga are ingested by small fish. Larger fish eat small fish, and humans, in turn, eat larger fish. The longer the lifespan, the more mercury accumulates in those people who have lost (phenotypic expression) or have innately impaired (genotypic expression) abilities to detoxify and eliminate these anthropogenic xenobiotic toxicants. Since accumulation of POPs takes place primarily in the fat while TM accumulates more prominently in muscle and bone cells and extracellular matrix, it follows that such toxins might contribute to the novel and more severe treatment-resistant musculoskeletal conditions observed in practice. Scientific evidence is also “bioaccumulating” for a clinical imperative to mitigate exposure where possible and to optimize innate host defenses, generally through strategic mental and functional, nutritional, and environmental adaptations. This article outlines the current standards of care for integrative medicine physicians incorporating the 2005 American Board of Clinical Metal Toxicology (ABCMT) training guidelines for practitioners. The practice of first line comprehensive care is emerging as outcome and cost effective compared with today’s conventions in most chronic diseases as well as in the implementation of proactive, cost-effective, and outcome-effective health promotion approaches. If not now, when will we implement widely what we know that cost effectively and outcome effectively promotes sustainable good health and general well being?

一线综合护理是综合医学的基础,这是美国医疗保健中的新兴专业。主要重点是功能性和预测性测试,以确定造成痛苦和健康不良的可补救原因。综合健康专业人员正在学习一种更实用的语言——它既是一种解释原因的语言,也是一种对我们健康和疾病的更基本的分子和亚分子机制的更深入的见解。人为的外来生物,特别是生物积累和生物浓缩的有毒矿物质(TMs)和持久性有机污染物(POPs)是本文的重点,因为它们的毒性更强,主要是人为的,人类来源的毒物。生物浓缩的运作方式如下:海洋磷虾和藻类将毒性较小的无机汞转化为具有生物毒性的有机汞。藻类是小鱼吃的。大鱼吃小鱼,反过来,人类也吃大鱼。寿命越长,汞在那些失去(表型表达)或先天受损(基因表达)解毒和消除这些人为外源毒物能力的人体内积累越多。由于持久性有机污染物的积累主要发生在脂肪中,而TM则主要积聚在肌肉和骨骼细胞以及细胞外基质中,因此,这些毒素可能会导致实践中观察到的新型和更严重的治疗抵抗性肌肉骨骼疾病。科学证据也在“生物积累”,表明临床迫切需要在可能的情况下减少暴露,并优化先天宿主防御,通常通过战略性的心理和功能、营养和环境适应。本文概述了结合2005年美国临床金属毒理学委员会(ABCMT)从业人员培训指南的中西医结合医生的现行护理标准。与目前大多数慢性病的惯例相比,在实施积极主动、具有成本效益和结果有效的健康促进方法方面,一线综合护理的做法正在成为结果和成本效益较高的做法。如果不是现在,我们什么时候才能广泛实施我们所知道的成本有效和结果有效地促进可持续良好健康和一般福祉的措施?
{"title":"First Line Comprehensive Care. Part II: Anthropogenic Xenobiotics in Functional Medicine. Managing Persisting Bioaccumulating Pollutants: Toxic Minerals, Biocides, Hormone Mimics, Solvents, and Chemical Disruptors","authors":"Russell Jaffe MD, PhD, CCN, NACB","doi":"10.1016/j.sigm.2005.11.001","DOIUrl":"10.1016/j.sigm.2005.11.001","url":null,"abstract":"<div><p><span>First line comprehensive care is fundamental to integrative medicine<span>, an emerging specialty within American healthcare. Primary focus is on functional and predictive tests to identify remediable causes of suffering and ill health. Integrative health professionals are learning a more functional language—it is both a language of causes and of deeper insights into more fundamental molecular and submolecular mechanisms of both our good health and our ill health. Anthropogenic xenobiotics, especially the bioaccumulating and bioconcentrating toxic minerals (TMs) and </span></span>persistent organic pollutants<span><span> (POPs) are the focus of this article as they are, in their more toxic forms, largely anthropogenic, human-sourced intoxicants. Bioconcentration operates in the following way: Ocean krill and algae convert less toxic, inorganic mercury to biotoxic </span>organic mercury<span>. Alga are ingested by small fish. Larger fish eat small fish, and humans, in turn, eat larger fish. The longer the lifespan, the more mercury accumulates in those people who have lost (phenotypic expression) or have innately impaired (genotypic expression) abilities to detoxify and eliminate these anthropogenic xenobiotic toxicants. Since accumulation of POPs takes place primarily in the fat while TM accumulates more prominently in muscle and bone cells and extracellular matrix, it follows that such toxins might contribute to the novel and more severe treatment-resistant musculoskeletal conditions observed in practice. Scientific evidence is also “bioaccumulating” for a clinical imperative to mitigate exposure where possible and to optimize innate host defenses, generally through strategic mental and functional, nutritional, and environmental adaptations. This article outlines the current standards of care for integrative medicine physicians incorporating the 2005 American Board of Clinical Metal Toxicology (ABCMT) training guidelines for practitioners. The practice of first line comprehensive care is emerging as outcome and cost effective compared with today’s conventions in most chronic diseases as well as in the implementation of proactive, cost-effective, and outcome-effective health promotion approaches. If not now, when will we implement widely what we know that cost effectively and outcome effectively promotes sustainable good health and general well being?</span></span></p></div>","PeriodicalId":101156,"journal":{"name":"Seminars in Integrative Medicine","volume":"3 3","pages":"Pages 79-92"},"PeriodicalIF":0.0,"publicationDate":"2005-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.sigm.2005.11.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86959786","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
New Orleans Pharmacy Museum 新奥尔良药房博物馆
Pub Date : 2005-09-01 DOI: 10.1016/j.sigm.2005.10.001
Jennifer Lushear Gick
{"title":"New Orleans Pharmacy Museum","authors":"Jennifer Lushear Gick","doi":"10.1016/j.sigm.2005.10.001","DOIUrl":"10.1016/j.sigm.2005.10.001","url":null,"abstract":"","PeriodicalId":101156,"journal":{"name":"Seminars in Integrative Medicine","volume":"3 3","pages":"Pages 77-78"},"PeriodicalIF":0.0,"publicationDate":"2005-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.sigm.2005.10.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"100285263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Seminars in Integrative Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1